Stay updated on ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Sign up to get notified when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.

Latest updates to the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study location entry was updated from Napoli, Italy to Naples, Italy. This aligns the listing with English-language naming conventions and improves readability of the site.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision: v3.5.0 implemented, replacing the previous v3.4.3. No visible changes to the study details or pages were detected.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Primary peritoneal carcinoma and Fallopian tube cancer to the study conditions, and updated the page to revision v3.4.2.SummaryDifference0.3%

- Check66 days agoChange DetectedA site-wide Notice was added stating a lapse in government funding may delay data updates and affect operations; a Revision: v3.4.1 was added, replacing the previous v3.4.0.SummaryDifference0.2%

- Check74 days agoChange DetectedAdded UI element: Show glossary, and updated the revision label to Revision: v3.4.0. Adjusted QC/FEAR Act wording and capitalization (Last Update... met QC Criteria; No FEAR Act data) to reflect the new version from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.